CovidChloroV1, Main, Corpus, bibRecord, 001620

Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.

Identifieur interne : 001620 ( Main/Corpus ); précédent : 001619; suivant : 001621

Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.

Auteurs : Carlos E. Rodríguez-Martínez ; Ricardo M. Fernandes ; Daniel B. Hawcutt ; Ian P. Sinha ; Rafael Leite Pacheco

Source :

Acta paediatrica (Oslo, Norway : 1992) [ 1651-2227 ] ; 2020.

RBID : pubmed:32438459

English descriptors

KwdEn :
- COVID-19 (drug therapy), Child (MeSH), Coronavirus Infections (drug therapy), Cost-Benefit Analysis (MeSH), Evidence-Based Medicine (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Hydroxychloroquine (economics), Hydroxychloroquine (therapeutic use), Treatment Outcome (MeSH).
MESH :
- chemical , adverse effects : Hydroxychloroquine.
- drug therapy : COVID-19, Coronavirus Infections.
- chemical , economics : Hydroxychloroquine.
- chemical , therapeutic use : Hydroxychloroquine.
- Child, Cost-Benefit Analysis, Evidence-Based Medicine, Humans, Treatment Outcome.

DOI: 10.1111/apa.15373
PubMed: 32438459
PubMed Central: PMC7280726

Links to Exploration step

pubmed:32438459

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.</title>
<author><name sortKey="Rodriguez Martinez, Carlos E" sort="Rodriguez Martinez, Carlos E" uniqKey="Rodriguez Martinez C" first="Carlos E" last="Rodríguez-Martínez">Carlos E. Rodríguez-Martínez</name>
<affiliation><nlm:affiliation>Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fernandes, Ricardo M" sort="Fernandes, Ricardo M" uniqKey="Fernandes R" first="Ricardo M" last="Fernandes">Ricardo M. Fernandes</name>
<affiliation><nlm:affiliation>Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hawcutt, Daniel B" sort="Hawcutt, Daniel B" uniqKey="Hawcutt D" first="Daniel B" last="Hawcutt">Daniel B. Hawcutt</name>
<affiliation><nlm:affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>NIHR Alder Hey Clinical Research Facility, Alder Hey, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sinha, Ian P" sort="Sinha, Ian P" uniqKey="Sinha I" first="Ian P" last="Sinha">Ian P. Sinha</name>
<affiliation><nlm:affiliation>Respiratory Department, Alder Hey Children's Hospital, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pacheco, Rafael Leite" sort="Pacheco, Rafael Leite" uniqKey="Pacheco R" first="Rafael Leite" last="Pacheco">Rafael Leite Pacheco</name>
<affiliation><nlm:affiliation>Disciplina de Economia e Gestão em Saúde, Universidade Federal de São Paulo (Unifesp), Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32438459</idno>
<idno type="pmid">32438459</idno>
<idno type="doi">10.1111/apa.15373</idno>
<idno type="pmc">PMC7280726</idno>
<idno type="wicri:Area/Main/Corpus">001620</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001620</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.</title>
<author><name sortKey="Rodriguez Martinez, Carlos E" sort="Rodriguez Martinez, Carlos E" uniqKey="Rodriguez Martinez C" first="Carlos E" last="Rodríguez-Martínez">Carlos E. Rodríguez-Martínez</name>
<affiliation><nlm:affiliation>Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Fernandes, Ricardo M" sort="Fernandes, Ricardo M" uniqKey="Fernandes R" first="Ricardo M" last="Fernandes">Ricardo M. Fernandes</name>
<affiliation><nlm:affiliation>Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hawcutt, Daniel B" sort="Hawcutt, Daniel B" uniqKey="Hawcutt D" first="Daniel B" last="Hawcutt">Daniel B. Hawcutt</name>
<affiliation><nlm:affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>NIHR Alder Hey Clinical Research Facility, Alder Hey, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Sinha, Ian P" sort="Sinha, Ian P" uniqKey="Sinha I" first="Ian P" last="Sinha">Ian P. Sinha</name>
<affiliation><nlm:affiliation>Respiratory Department, Alder Hey Children's Hospital, Liverpool, UK.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pacheco, Rafael Leite" sort="Pacheco, Rafael Leite" uniqKey="Pacheco R" first="Rafael Leite" last="Pacheco">Rafael Leite Pacheco</name>
<affiliation><nlm:affiliation>Disciplina de Economia e Gestão em Saúde, Universidade Federal de São Paulo (Unifesp), Sao Paulo, Brazil.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Acta paediatrica (Oslo, Norway : 1992)</title>
<idno type="eISSN">1651-2227</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (drug therapy)</term>
<term>Child (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Cost-Benefit Analysis (MeSH)</term>
<term>Evidence-Based Medicine (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Hydroxychloroquine (economics)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Treatment Outcome (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
<term>Coronavirus Infections</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Child</term>
<term>Cost-Benefit Analysis</term>
<term>Evidence-Based Medicine</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32438459</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1651-2227</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>109</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Acta paediatrica (Oslo, Norway : 1992)</Title>
<ISOAbbreviation>Acta Paediatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.</ArticleTitle>
<Pagination><MedlinePgn>1711-1712</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/apa.15373</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodríguez-Martínez</LastName>
<ForeName>Carlos E</ForeName>
<Initials>CE</Initials>
<Identifier Source="ORCID">0000-0003-2560-6693</Identifier>
<AffiliationInfo><Affiliation>Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Fernandes</LastName>
<ForeName>Ricardo M</ForeName>
<Initials>RM</Initials>
<Identifier Source="ORCID">0000-0002-7253-6475</Identifier>
<AffiliationInfo><Affiliation>Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisboa, Portugal.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hawcutt</LastName>
<ForeName>Daniel B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo><Affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>NIHR Alder Hey Clinical Research Facility, Alder Hey, Liverpool, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sinha</LastName>
<ForeName>Ian P</ForeName>
<Initials>IP</Initials>
<AffiliationInfo><Affiliation>Respiratory Department, Alder Hey Children's Hospital, Liverpool, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pacheco</LastName>
<ForeName>Rafael Leite</ForeName>
<Initials>RL</Initials>
<Identifier Source="ORCID">0000-0001-7487-8471</Identifier>
<AffiliationInfo><Affiliation>Disciplina de Economia e Gestão em Saúde, Universidade Federal de São Paulo (Unifesp), Sao Paulo, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Norway</Country>
<MedlineTA>Acta Paediatr</MedlineTA>
<NlmUniqueID>9205968</NlmUniqueID>
<ISSNLinking>0803-5253</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003362" MajorTopicYN="N">Cost-Benefit Analysis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019317" MajorTopicYN="N">Evidence-Based Medicine</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>05</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>05</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32438459</ArticleId>
<ArticleId IdType="doi">10.1111/apa.15373</ArticleId>
<ArticleId IdType="pmc">PMC7280726</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>CMAJ. 2020 Apr 27;192(17):E450-E453</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32269021</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Rev Allergy Immunol. 2012 Apr;42(2):145-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21221847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Paediatr. 2020 Sep;109(9):1711-1712</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32438459</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Diabetes Metab Syndr. 2020 May - Jun;14(3):241-246</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32247211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Apr 13;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32282022</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Pediatr Pulmonol. 2020 Jun;55(6):E6-E9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32243729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Account Res. 2017;24(1):1-29</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27294429</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001620 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001620 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32438459
   |texte=   Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32438459" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.

Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki